David Altshuler, EVP, Global Research and CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,653 shares at $306.70 ($505K) on 2023-02-06, disclosed to the SEC on 2023-02-08.
Seasonal sale ($505k) by EVP, Global Research and CSO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.39 | 12 | $4K | 0.7% |
| 2 | $302.00 | 70 | $21K | 4.2% |
| 3 | $303.64 | 100 | $30K | 6.0% |
| 4 | $305.08 | 349 | $106K | 21.1% |
| 5 | $305.08 | 349 | $106K | 21.1% |
| 6 | $306.70 | 620 |
| $190K |
| 37.6% |
| 7 | $309.06 | 153 | $47K | 9.4% |
| Total | $305.80 avg | 1,653 | $505K | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-03-05 | $1.6M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $611K | — | Filing → |